VOYA Investment Management
AEGR

VOYA Investment Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

VOYA Investment Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,629
Closed -$47K – 2614
2016
Q1 		$47K Hold
12,629
– – ﹤0.01% 2480
2015
Q4 		$128K Hold
12,629
– – ﹤0.01% 2425
2015
Q3 		$172K Sell
12,629
-3,842
-23% -$68.4K ﹤0.01% 2333
2015
Q2 		$312K Sell
16,471
-1,782
-10% -$38.6K ﹤0.01% 2234
2015
Q1 		$478K Hold
18,253
– – ﹤0.01% 1942
2014
Q4 		$382K Hold
18,253
– – ﹤0.01% 2112
2014
Q3 		$609K Hold
18,253
– – ﹤0.01% 1768
2014
Q2 		$586K Hold
18,253
– – ﹤0.01% 1864
2014
Q1 		$842K Hold
18,253
– – ﹤0.01% 1575
2013
Q4 		$1.29M Hold
18,253
– – ﹤0.01% 1299
2013
Q3 		$1.56M Hold
18,253
– – ﹤0.01% 1199
2013
Q2 		$1.16M Buy
+18,253
New +$969K ﹤0.01% 1311

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

VOYA Investment Management's AEGR Position: Q2 2016 in Review

VOYA Investment Management sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 12,629 shares — an estimated $47K sold.

VOYA Investment Management first reported a position in AEGR in Q2 2013 and held it in 12 quarters. The position peaked at $1.56M in Q3 2013. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

  • VOYA Investment Management reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • VOYA Investment Management sold 12,629 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $47K.
  • VOYA Investment Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • VOYA Investment Management's Aegerion Pharmaceuticals position peaked at $1.56M in Q3 2013.
  • 71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on VOYA Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.